Lipoprotein(a) and the risk of cardiovascular disease in the European population: results from the BiomarCaRE consortium

As promising compounds to lower Lipoprotein(a) (Lp(a)) are emerging, the need for a precise characterization and comparability of the Lp(a)-associated cardiovascular risk is increasing. Therefore, we aimed to evaluate the distribution of Lp(a) concentrations across the European population, to charac...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European heart journal Jg. 38; H. 32; S. 2490
Hauptverfasser:	Waldeyer, Christoph, Makarova, Nataliya, Zeller, Tanja, Schnabel, Renate B, Brunner, Fabian J, Jørgensen, Torben, Linneberg, Allan, Niiranen, Teemu, Salomaa, Veikko, Jousilahti, Pekka, Yarnell, John, Ferrario, Marco M, Veronesi, Giovanni, Brambilla, Paolo, Signorini, Stefano G, Iacoviello, Licia, Costanzo, Simona, Giampaoli, Simona, Palmieri, Luigi, Meisinger, Christa, Thorand, Barbara, Kee, Frank, Koenig, Wolfgang, Ojeda, Francisco, Kontto, Jukka, Landmesser, Ulf, Kuulasmaa, Kari, Blankenberg, Stefan
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	England 21.08.2017
Schlagworte:	Adult Biomarkers - metabolism Cardiovascular Diseases - etiology Cardiovascular Diseases - mortality Europe - epidemiology Female Humans Kaplan-Meier Estimate Lipoprotein(a) - metabolism Lipoprotein(a) - physiology Male Middle Aged Prognosis Prospective Studies Residence Characteristics - statistics & numerical data Risk Assessment BiomarCaRE (Biomarker for Cardiovascular Risk Assessment in Europe) Lipoprotein(a) MORGAM (MONICA Risk Genetics Archiving and Monograph) Mortality Cardiovascular risk
ISSN:	1522-9645, 1522-9645
Online-Zugang:	Weitere Angaben
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!